Radnor Capital Management LLC reduced its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 0.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,542 shares of the financial services provider’s stock after selling 425 shares during the quarter. Aflac accounts for 1.1% of Radnor Capital Management LLC’s portfolio, making the stock its 17th largest position. Radnor Capital Management LLC’s holdings in Aflac were worth $6,912,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. AlphaCore Capital LLC purchased a new stake in Aflac during the first quarter worth approximately $28,000. Golden State Wealth Management LLC grew its stake in Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock worth $34,000 after buying an additional 167 shares during the period. Groupe la Francaise purchased a new stake in Aflac during the first quarter worth approximately $34,000. Garde Capital Inc. purchased a new stake in Aflac during the first quarter worth approximately $36,000. Finally, Meeder Asset Management Inc. boosted its stake in shares of Aflac by 90.8% in the first quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider’s stock valued at $37,000 after purchasing an additional 157 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Aflac
In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the completion of the transaction, the director owned 25,105 shares in the company, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.80% of the company’s stock.
Aflac Stock Down 0.8%
Aflac (NYSE:AFL – Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The financial services provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.71 by $0.07. The business had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 15.32% and a return on equity of 15.08%. The company’s quarterly revenue was down 19.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.83 earnings per share. As a group, equities analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac declared that its Board of Directors has initiated a share buyback plan on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
Aflac Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were given a dividend of $0.58 per share. The ex-dividend date was Wednesday, August 20th. This represents a $2.32 annualized dividend and a dividend yield of 2.2%. Aflac’s dividend payout ratio is currently 52.61%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. UBS Group decreased their target price on shares of Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Raymond James Financial decreased their target price on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research note on Thursday, May 29th. Morgan Stanley upped their target price on shares of Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research note on Monday, August 18th. Evercore ISI reaffirmed an “underperform” rating and issued a $106.00 price target (up from $105.00) on shares of Aflac in a report on Thursday, August 14th. Finally, Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Saturday, August 9th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Aflac presently has a consensus rating of “Hold” and an average target price of $109.15.
Check Out Our Latest Stock Report on AFL
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- What Are Dividend Challengers?
- Is It Time to Trim Your Positions in These 2 AI Stocks?
- What Are Treasury Bonds?
- These 3 Tech Stocks Just Supercharged Their Buybacks
- What Are Trending Stocks? Trending Stocks Explained
- 3 Dividend Stocks to Hold Through Market Volatility This Fall
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.